Best Health News

Advertisers



Recent comments

Who's online

There are currently 0 users and 12 guests online.
Home

TomoTherapy Tops MD Buyline Rankings for Second Straight Quarter

Quality (70)
Helpful (80)
TomoTherapy Incorporated (NASDAQ: TOMO), maker of the TomoTherapy® Hi·Art® treatment system for advanced radiation therapy, has earned top honors in MD Buyline’s user satisfaction rankings for the second consecutive quarter, solidifying its position as the customer service leader in linear accelerator-based radiation therapy. Read the full story at http://ca.prweb.com/releases/tomotherapy/md_buyline/prweb1072684.htm
Technorati Tags: Array
Submitted by root on Thu, 2008-07-03 05:26.

Post new comment

The content of this field is kept private and will not be shown publicly.
  • Filtered words will be replaced with the filtered version of the word.
  • Lines and paragraphs break automatically.
  • You can use Textile markup to format text.
  • Allowed HTML tags: <a> <em> <strong> <cite> <code> <ul> <ol> <li> <dl> <dt> <dd> <img>
More information about formatting options

Similar entries

  • TomoTherapy Tops MD Buyline Rankings for Second Straight Quarter

    TomoTherapy Incorporated (NASDAQ: TOMO), maker of the TomoTherapy® Hi·Art® treatment system for advanced radiation therapy, has earned top honors in MD Buyline’s user satisfaction rankings for the second consecutive quarter, solidifying its position as the customer service leader in linear accelerator-based radiation therapy. (PRWeb Jul 2, 2008)

    Read the full story at http://www.prweb.com/releases/tomotherapy/md_buyline/prweb1072684.htm

  • TomoTherapy Earns Top Honors in MD Buyline Review of Radiation Therapy Vendors

    TomoTherapy Incorporated (NASDAQ: TOMO) today announced that it has earned the top user satisfaction composite rating among four vendors in the linear accelerator-based radiation therapy marketplace. The ratings appear in MD Buyline's Quarterly User Satisfaction Report, which was published on April 15, 2008. (PRWeb May 28, 2008)

    Read the full story at http://ca.prweb.com/releases/tomotherapy/md_buyline/prweb978294.htm

  • TomoTherapy Earns Top Honors in MD Buyline Review of Radiation Therapy Vendors

    TomoTherapy Incorporated (NASDAQ: TOMO) today announced that it has earned the top user satisfaction composite rating among four vendors in the linear accelerator-based radiation therapy marketplace. The ratings appear in MD Buyline's Quarterly User Satisfaction Report, which was published on April 15, 2008. (PRWeb May 28, 2008)

    Read the full story at http://www.prweb.com/releases/tomotherapy/md_buyline/prweb978294.htm

  • TomoTherapy Issues Treatment Quality Challenge

    TomoTherapy Incorporated (NASDAQ:TOMO), maker of the TomoTherapy(R) Hi-Art(R) treatment system for advanced radiation therapy, announced today that it has issued a Treatment Quality Challenge. TomoTherapy will award $250,000 to any U.S. cancer center that demonstrates its ability to beat the quality of a TomoTherapy(SM) treatment plan using the new RapidArc(TM) product from Varian Medical Systems. (PRWeb Mar 26, 2008)

    Read the full story at http://ca.prweb.com/releases/tomotherapy/trea

  • TomoTherapy Issues Treatment Quality Challenge

    TomoTherapy Incorporated (NASDAQ:TOMO), maker of the TomoTherapy(R) Hi-Art(R) treatment system for advanced radiation therapy, announced today that it has issued a Treatment Quality Challenge. TomoTherapy will award $250,000 to any U.S. cancer center that demonstrates its ability to beat the quality of a TomoTherapy(SM) treatment plan using the new RapidArc(TM) product from Varian Medical Systems. (PRWeb Mar 26, 2008)

    Read the full story at http://www.prweb.com/releases/tomotherapy/tr

  • TomoTherapy Concludes Treatment Quality Challenge

    TomoTherapy Incorporated (NASDAQ:TOMO), maker of the TomoTherapy® Hi·Art® treatment system for advanced radiation therapy, today announced the close of its Treatment Quality Challenge. The company had offered $250,000 to any U.S. cancer center that could surpass the quality of a helical TomoTherapySM treatment plan using a single-rotation Varian RapidArc™ plan delivered in two minutes or less. The three-month program ended on June 30, 2008, without a single entry. (PRWeb Jul 1, 2008)

    Read the full story at

    TomoTherapy Incorporated (NASDAQ:TOMO), maker of the TomoTherapy® Hi·Art® treatment system for advanced radiation therapy, today announced the close of its Treatment Quality Challenge. The company had offered $250,000 to any U.S. cancer center that could surpass the quality of a helical TomoTherapySM treatment plan using a single-rotation Varian RapidArc™ plan delivered in two minutes or less. The three-month program ended on June 30, 2008, without a single entry. (PRWeb Jul 1, 2008)

    Read the full story at

    TomoTherapy Incorporated (NASDAQ: TOMO), maker of the Hi-Art(R) treatment system for advanced radiation therapy, held an investor meeting on March 13, 2008, at its headquarters in Madison, Wis. The event, arranged by investment firm William Blair & Company, included presentations from TomoTherapy's management team and two clinical experts in the field of radiation oncology: Patrick Kupelian, M.D., and Chet Ramsey, Ph.D. (PRWeb Mar 20, 2008)

    Read the full story at http://www.prweb.com/